An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Cited by (1,002)

Items 701–800 of 1,002

1. Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis
   Arlou Kristina Angeles, Petros Christopoulos, Zhao Kang Yuan, Simone Bauer, Florian Janke, Simon J. Ogrodnik, Martin Reck, Matthias Schlesner, Michael A. Meister, Marc Andre Schneider et al. · 2021 · npj Precision Oncology
2. Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma
   Xin Wang, Nuo Yu, Guowei Cheng, Tao Zhang, Jianyang Wang, Lei Deng, Jiao Li, Xiaotian Zhao, Yang Xu, Peng Yang et al. · 2022 · Clinical and Translational Medicine
3. The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients
   Ugur Deligezer, Abel Jacobus Bronkhorst, Stefan Holdenrieder · 2022 · Diagnostics
4. Circulating Tumor Cells as a Predictive Biomarker in Resectable Lung Cancer: A Systematic Review and Meta-Analysis
   Durgesh Wankhede, Sandeep Grover, Paul M Hofman · 2022 · Cancers
5. A novel strategy for highly efficient isolation and analysis of circulating tumor-specific cell-free DNA from lung cancer patients using a reusable conducting polymer nanostructure
   Hyungjae Lee, Seunghyun Jeon, Jin-Suck Seo, Sung‐Ho Goh, Ji‐Youn Han, Youngnam Cho · 2016 · Biomaterials
6. Blood-based Biomarkers for Early Diagnosis of Lung Cancer: A Review Article
   Narayani Maharjan, Niresh Thapa, Jiancheng Tu · 2020 · Journal of Nepal Medical Association
7. Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
   Jialiang Yang, Hui Yan, Yan-xiang Zhang, Minghui Zhang, Binbin Ji, Geng Tian, Yangqiang Guo, Min Tang, Lianxing Li, Bella Guo et al. · 2021 · Frontiers in Oncology
8. Recent advances of graphene–biomacromolecule nanocomposites in medical applications
   Yiting Wang, Shuhan Di, Jinhui Yu, Li Wang, Zhuang Li · 2022 · Journal of Materials Chemistry B
9. Liquid Biopsy Approaches for Cancer Characterization, Residual Disease Detection, and Therapy Monitoring
   Jacqueline V. Aredo, Amna Jamali, Jessica Zhu, Natalie Knox Heater, Heather A. Wakelee, Christos Vaklavas, Valsamo Anagnostou, Janice M. Lu · 2025 · American Society of Clinical Oncology Educational Book
10. Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer
    Chien‐Chung Lin, Wei-Lun Huang, Wei Fang, Wu‐Chou Su, David T. Wong · 2015 · Expert Review of Molecular Diagnostics
11. Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas
    Mary Kwok, Shengyang Peter Wu, Clifton Craig Mo, Thomas A. Summers, Mark J. Roschewski · 2016 · Current Treatment Options in Oncology
12. Liquid biopsy in early stage lung cancer
    Cristina Pérez-Ramírez, Marisa Cañadas‐Garre, Ana I. Robles, Miguel Ángel Molina‐Vila, María José Faus-Dáder, Miguel Ángel Calleja‐Hernández · 2016 · Translational Lung Cancer Research
13. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer
    Nikolas C. C. von Bubnoff · 2017 · Oncology Research and Treatment
14. Enrichment of extracellular vesicles with lipid nanoprobe functionalized nanostructured silica
    Yuan Wan, Mackenzie Maurer, Hong-Zhang He, Yi-Qiu Xia, Si-Jie Hao, Wen-Long Zhang, Nelson S. Yee, Siyang Zheng · 2019 · Lab on a Chip
15. The liquid biopsy in lung cancer
    Junaid Ansari, Jungmi W. Yun, Anvesh Reddy Kompelli, Youmna E. Moufarrej, Jonathan Steven Alexander, Guillermo A. Herrera, Rodney E. Shackelford · 2017 · Genes & Cancer
16. Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer
    Eva Boysen Fynboe Ebert, Tine McCulloch, Karin Holmskov Hansen, Hanne Linnet, Boe Sandahl Sørensen, Peter Meldgaard · 2019 · Lung Cancer
17. TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer
    Silvia Rita Vitale, Floris H. Groenendijk, Ronald van Marion, Corine M. Beaufort, Jean Helmijr, Hendrikus Jan Dubbink, Winand N.M. Dinjens, Patricia C. Ewing‐Graham, Ramon G. V. Smolders, Helena C. van Doorn et al. · 2020 · Biomolecules
18. Machine Learning‐Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer Screening
    Rita Tanos, Guillaume Tosato, Amaëlle Otandault, Zahra Al Amir Dache, Laurence Lasorsa, Geoffroy Tousch, Safia El Messaoudi, Romain Meddeb, Mona Diab Assaf, Marc Ychou et al. · 2020 · Advanced Science
19. Clinical management and biology of tumor dormancy in breast cancer
    Stefan Werner, Isabel Heidrich, Klaus Pantel · 2021 · Seminars in Cancer Biology
20. Current advances in detecting genetic and epigenetic biomarkers of colorectal cancer
    Md. Sajedul Islam, Vinod Gopalan, Alfred King-yin Lam, Muhammad J. A. Shiddiky · 2023 · Biosensors and Bioelectronics
21. Liquid biopsy for early cancer detection: technological revolutions and clinical dilemma
    Sidney W. Fu, Cong Tang, Xiaohui Tan, Sudhir Srivastava · 2024 · Expert Review of Molecular Diagnostics
22. Liquid biopsy
    Isabelle Gingras, Roberto Salgado, Michail Ignatiadis · 2015 · Current Opinion in Oncology
23. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing
    Bianhong Wang, Yangyang Liu, Guangyuan Hou, Lili Wang, Na Lv, Yuanyuan Xu, Yihan Xu, Xiuli Wang, Zhaoling Xuan, Yu Jing et al. · 2016 · Oncotarget
24. Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing
    Chiaki Nakauchi, Naofumi Kagara, Kenzo Shimazu, Atsushi Shimomura, Yasuto Naoi, Masafumi Shimoda, Seung Jin Kim, Shinzaburo Noguchi · 2016 · Clinical Breast Cancer
25. Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns
    Xiangyuan Ma, Liangjun Zhu, Xue Wu, Hua Bao, Xiaonan Wang, Zhili Chang, Yang Washington Shao, Zhenxin Wang · 2017 · PLoS ONE
26. Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing
    Takehiro Yanagawa, Naofumi Kagara, Tomohiro Miyake, Tomonori Tanei, Yasuto Naoi, Masafumi Shimoda, Kenzo Shimazu, Seung Jin Kim, Shinzaburo Noguchi · 2017 · Breast Cancer Research and Treatment
27. DNA terminal structure-mediated enzymatic reaction for ultra-sensitive discrimination of single nucleotide variations in circulating cell-free DNA
    Tongbo Wu, Wei Chen, Wenlong Yang, Haocheng Tan, Jiayu Wang, Xianjin Xiao, Mengyuan Li, Meiping Zhao · 2017 · Nucleic Acids Research
28. Circulating Tumour DNA in EGFR-Mutant Non-Small-Cell Lung Cancer
    Michael Cabanero, Ming‐Sound Tsao · 2018 · Current Oncology
29. Circulating Tumor Cells and Circulating Tumor DNA
    Evi S. Lianidou, Dave S.�B. Hoon · 2018 · Elsevier eBooks
30. Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST)
    Stefanie Jilg, Michael P. Rassner, Jacqueline Maier, Silvia Waldeck, Victoria Kehl, Marie Follo, Ulrike Philipp, Andreas Philipp Sauter, Katja Specht, Jan Mitschke et al. · 2019 · International Journal of Cancer
31. Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution
    Vanessa D. Jönsson, Collin M. Blakely, Luping Lin, Saurabh Asthana, Nikolai Matni, Victor R. Olivas, Evangelos Pazarentzos, Matthew A. Gubens, Boris C. Bastian, Barry S. Taylor et al. · 2017 · Scientific Reports
32. Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer
    Élisa Gobbini, Aurélie Swalduz, Matteo Giaj Levra, Sandra Ortiz‐Cuaran, Anne‐Claire Toffart, Maurice Pérol, Denis Moro‐Sibilot, Pierre Saintigny · 2020 · Cancers
33. Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma
    Gehan Botrus, Heidi Kosirorek, Mohamad Bassam Sonbol, Yael N. Kusne, Pedro Luiz Serrano Usón, Mitesh J. Borad, Daniel H. Ahn, Pashtoon Murtaza Kasi, Leylah M. Drusbosky, Hiba I. Dada et al. · 2021 · The Oncologist
34. Clinical implementation and current advancement of blood liquid biopsy in cancer
    Kazunori Watanabe, Yusuke Nakamura, Siew‐Kee Low · 2021 · Journal of Human Genetics
35. Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies
    Chang Lu, Jinming Li, Rui Zhang · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
36. Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
    Joseph G. Schroers‐Martin, Joanne Soo, Gabriel Brisou, Florian Scherer, David Matthew Kurtz, Brian J. Sworder, Michael Siavash Khodadoust, Michael Chuwei Jin, Agnès Bru, Chih Long Liu et al. · 2023 · Cancer Discovery
37. Circulating Tumor DNA in the Management of Early-Stage Breast Cancer
    Katerina Vlataki, Sevastiani Antonouli, Christina Kalyvioti, Evangeli S. Lampri, Sevasti Kamina, Davide Mauri, Haralampos V. Harissis, Angeliki Magklara · 2023 · Cells
38. Can oncology recapitulate paleontology? Lessons from species extinctions
    Viola Walther, Crispin T. Hiley, Darryl K. Shibata, Charles Swanton, Paul E. Turner, Carlo C. Maley · 2015 · Nature Reviews Clinical Oncology
39. Targeted Deep DNA Methylation Analysis of Circulating Cell-free DNA in Plasma Using Massively Parallel Semiconductor Sequencing
    Felipe Vaca‐Paniagua, Javier Oliver, André Nogueira da Costa, Philippe Merle, James McKay, Zdenko Herceg, Reetta J. Holmila · 2015 · Epigenomics
40. SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients
    Julia T. Stadler, Johanna Eder, Barbara Pratscher, Sabine Brandt, Doris Schneller, Robert ­Müllegger, Claus Vogl, Franz Trautinger, Gottfried Brem, Joerg Patrick Burgstaller · 2015 · PLoS ONE
41. Template-Independent, in Situ Grown DNA Nanotail Enabling Label-Free Femtomolar Chronocoulometric Detection of Nucleic Acids
    Fan Yang, Xian Jin Yang, Yunzhao Wang, You Qin, Xiang Liu, Xiaoqian Yan, Ke Zou, Yong Ning, Guojun Zhang · 2014 · Analytical Chemistry
42. Biomarkers of risk to develop lung cancer in the new screening era
    Thomas Atwater, Pierre P. Massion · 2016 · Annals of Translational Medicine
43. A Rare STRN-ALK Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing–Based Circulating Tumor DNA Profiling Exhibits Excellent Response to Crizotinib
    Yan Fang Yang, Shukui Qin, Jian Zhu, Rui Wang, Yumei Li, Zongyu Xie, Qiong Wu · 2017 · Mayo Clinic Proceedings Innovations Quality & Outcomes
44. The Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources
    Ewy A. Mathé, John L. Hays, Daniel G. Stover, James L. Chen · 2018 · Yearbook of Medical Informatics
45. Prognostic factors for multiple myeloma in the era of novel therapies
    Dimitrios C. Ziogas, Meletios Athanasios Dimopoulos, Efstathios Kastritis · 2018 · Expert Review of Hematology
46. Recent Advances in Liquid Biopsy in Precision Oncology Research
    Yoshiharu Sato, Ryo Matoba, Kikuya Kato · 2019 · Biological and Pharmaceutical Bulletin
47. Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer
    Bin Zhang, Xueliang Niu, Qiang Zhang, Chunli Wang, Bo Liu, Dongsheng Yue, Chenguang Li, Giuseppe Giaccone, Shiyong Li, Liuwei Gao et al. · 2019 · Lung Cancer
48. Circulating tumor DNA in colorectal cancer: opportunities and challenges.
    Feifei Bi, Qiwei Wang, Qian Dong, Yuanhe Wang, Liqun Zhang, Jingdong Zhang · 2020 · PubMed Central
49. Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
    Giorgio Patelli, Caterina Vaghi, Federica Tosi, Gianluca Mauri, Alessio Amatu, Daniela Massihnia, Silvia Ghezzi, Erica Francesca Bonazzina, Katia Bruna Bencardino, Giulio Cerea et al. · 2021 · Targeted Oncology
50. Clinical and genomic features of Chinese lung cancer patients with germline mutations
    Wenying Peng, Bin Li, Jin Li, Lianpeng Chang, Jing Bai, Yuting Yi, Rongrong Chen, Yanyan Zhang, Chen Chen, Xingxiang Pu et al. · 2022 · Nature Communications
51. Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)
    Meichen Li, Jing Chen, Baishen Zhang, Juan Yu, Na Wang, Delan Li, Yang Washington Shao, Dongqin Zhu, Chuqiao Liang, Yutong Ma et al. · 2022 · BMC Medicine
52. Established and Novel Prognostic Biomarkers in Multiple Myeloma
    Mark W. Bustoros, Tarek H. Mouhieddine, Alexandre Detappe, Irene M. Ghobrial · 2017 · American Society of Clinical Oncology Educational Book
53. Circulating Exosome Cargoes Contain Functionally Diverse Cancer Biomarkers: From Biogenesis and Function to Purification and Potential Translational Utility
    Megan I. Mitchell, Junfeng Ma, Claire L. Carter, Olivier D. Loudig · 2022 · Cancers
54. Neutrophil ALDH2 is a new therapeutic target for the effective treatment of sepsis-induced ARDS
    Changchang Xu, Lin Zhang, Shaoyu Xu, Zichen Wang, Qi Han, Ying Lv, Xingfang Wang, Xiangxin Zhang, Qingju Zhang, Ying Zhang et al. · 2024 · Cellular and Molecular Immunology
55. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing
    Kazuko Sakai, Junji Tsurutani, Takeharu Yamanaka, Azusa Yoneshige, Akihiko Ito, Yosuke Togashi, Marco Antonio De Velasco, Masato Terashima, Yoshihiko Fujita, Shuta Tomida et al. · 2015 · PLoS ONE
56. Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer
    Cécile Jovelet, Jordan Madic, Jordi Remón, Aurélie Honoré, Romain Girard, Étienne Rouleau, Barbara André, Benjamin Besse, Magali Droniou, Ludovic Lacroix · 2017 · PLoS ONE
57. Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer
    Liping Liu, Han Liu, Ди Шао, Liu Zu, Jingjing Wang, Qiuhua Deng, Hailin Tang, Haihong Yang, Yalei Zhang, Yuan Qiu et al. · 2017 · Genes Chromosomes and Cancer
58. Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA
    Wey Cheng Sim, Chet Hong Loh, Grace Li-Xian Toh, Chia Wei Lim, Akhil Chopra, Alex Yuan Chi Chang, Liuh Ling Goh · 2018 · Lung Cancer
59. Circulating cell-free tumor DNA analysis in pediatric cancers
    Daniel Andersson, Henrik Fagman, Martin G. Dalin, Anders Ståhlberg · 2019 · Molecular Aspects of Medicine
60. Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response
    Ruiyu Li, Zhi-Yong Liang · 2020 · Chinese Medical Journal
61. Expanding detection windows for discriminating single nucleotide variants using rationally designed DNA equalizer probes
    Guan Alex Wang, Xiaoyu Xie, Hayam Hamza Mansour, Fangfang Chen, Gabriela Matamoros, Ana Lourdes Sanchez, Chunhai Fan, Feng Li · 2020 · Nature Communications
62. Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma
    Adam J. Olszewski, Anna Dorota Chorzalska, Max Petersen, Thomas A. Ollila, Adam S. Zayac, Habibe Kurt, Diana Olguta Treaba, John Leonard Reagan, Andrew Hsu, Pamela Egan et al. · 2021 · Blood Advances
63. Advances in the diagnosis, evaluation, and management of leptomeningeal disease
    Ugur T. Sener, Priya Kumthekar, Adrienne Ann Boire · 2021 · Neuro-Oncology Advances
64. Current concepts of anti-EGFR targeting in metastatic colorectal cancer
    Bernhard Doleschal, Andreas Petzer, Holger F. Rumpold · 2022 · Frontiers in Oncology
65. FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor
    Anniina Färkkilä, Melissa K. McConechy, Winnie Yang, Aline Talhouk, Ying Ng, Amy M. Lum, Ryan D. Morin, Kevin R. Bushell, Annika Riska, Jessica Nell McAlpine et al. · 2016 · Journal of Molecular Diagnostics
66. Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck
    Enrique Sanz‐García, Jinfeng Zou, Lisa M. Avery, Anna Spreafico, John N. Waldron, David Paul Goldstein, Aaron Richard Hansen, John Cho, John R. de Almeida, Andrew J. Hope et al. · 2024 · Cell Death and Differentiation
67. Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid
    Ryosuke Otsuji, Yutaka Fujioka, Nobuhiro Hata, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Akira Nakamizo, Masahiro Mizoguchi, Koji Yoshimoto · 2024 · Cancers
68. Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC
    Tae Hee Hong, Soohyun Hwang, Abhijit Dasgupta, Christopher Abbosh, Tiffany Hung, Joerg Bredno, Jill Walker, Xiaojin Shi, Tsveta Milenkova, Leora Horn et al. · 2024 · Journal of Thoracic Oncology
69. Minimal residual disease in non‐Hodgkin lymphoma – current applications and future directions
    Matthew Lewis Chase, Philippe A. Armand · 2017 · British Journal of Haematology
70. Role of circulating tumor DNA in the management of early‐stage lung cancer
    Heng Zhao, Kezhong Chen, Bengang Hui, Kai Zhang, Fan Yang, Jun Wang · 2018 · Thoracic Cancer
71. A Novel Method to Detect Early Colorectal Cancer Based on Chromosome Copy Number Variation in Plasma
    Junfeng Xu, Qian Kang, Xing-yong Ma, Yuanming Pan, Lang Yang, Peng Jin, Xin Wang, Chenguang Li, Xiaochen Chen, Chao Wu et al. · 2018 · Cellular Physiology and Biochemistry
72. Cell-Free Plasma DNA for Disease Stratification and Prognosis in Head and Neck Cancer
    Markus Schirmer, Julia Beck, Martin Leu, Michael Oellerich, Margret Rave‐Fränk, Philip D. Walson, Ekkehard Schütz, Martin Canis · 2018 · Clinical Chemistry
73. Monitoring Melanoma Using Circulating Free DNA
    Russell J. Diefenbach, Jenny Lee, Helen Rizos · 2018 · American Journal of Clinical Dermatology
74. The potential of ctDNA analysis in breast cancer
    Eleni Tzanikou, Evi S. Lianidou · 2019 · Critical Reviews in Clinical Laboratory Sciences
75. Development of circulating tumour DNA analysis for gastrointestinal cancers
    Yoshiaki Nakamura, Kohei Shitara · 2020 · ESMO Open
76. Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic Impact
    Tomoko Noguchi, Naoyuki Iwahashi, Kazuko Sakai, Kaho Matsuda, Hitomi Matsukawa, Saori Toujima, Kazuto Nishio, Kazuhiko Ino · 2020 · Cancers
77. Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with GenexusTM integrated sequencer
    Siew‐Kee Low, Ryo Ariyasu, Ken Uchibori, Rie Hayashi, Ting Chan, Yoon Ming Chin, Takahiro Akita, Yuhei Harutani, Ayu Kiritani, Ryosuke Tsugitomi et al. · 2022 · Translational Lung Cancer Research
78. Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients
    Kirsty Taylor, Jinfeng Zou, Marcos Aurélio Fonseca Magalhães, Marc Oliva, Anna Spreafico, Aaron Richard Hansen, Simon S. McDade, Vicky M. Coyle, Mark Lawler, Elena C. Elimova et al. · 2023 · European Journal of Cancer
79. Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
    Soyeong Jun, Nikhil Atul Shukla, Greg Andrew Durm, Angela Bik‐Yu Hui, Sha Cao, Apar Kishor Ganti, Salma K. Jabbour, Christian A. Kunder, Ash A. Alizadeh, Nasser H. Hanna et al. · 2024 · Journal of Thoracic Oncology
80. Activation of endogenous human stem cell-associated retroviruses (SCARs) and therapy-resistant phenotypes of malignant tumors
    Gennadi V. Glinsky · 2016 · Cancer Letters
81. Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors
    Meenakshi Mehrotra, Rajesh R. Singh, Sanam Loghavi, Dzifa Y. Duose, Bedia A. Barkoh, Carmen Behrens, Keyur Pravinchandra Patel, Mark J. Routbort, Scott Kopetz, Russell R. Broaddus et al. · 2017 · Oncotarget
82. ERASE-Seq: Leveraging replicate measurements to enhance ultralow frequency variant detection in NGS data
    Nick Kamps‐Hughes, Andrew McUsic, Laurie Jo Kurihara, Timothy T. Harkins, Prithwish Pal, Claire Ray, Cristian Ionescu‐Zanetti · 2018 · PLoS ONE
83. Disparities in survival by insurance status in follicular lymphoma
    Jordan Goldstein, Loretta J. Nastoupil, Xuesong Han, Ahmedin Jemal, Elizabeth Ward, Christopher R. Flowers · 2018 · Blood
84. Liquid biopsy to monitor melanoma patients
    Maria Rita Gaiser, Nikolas C. C. von Bubnoff, Christoffer Gebhardt, Jochen Sven Utikal · 2018 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
85. Surface Enhanced Raman Spectroscopy of Lactoferrin Adsorbed on Silvered Porous Silicon Covered with Graphene
    Siarhei A. Zavatski, Nadzeya Khinevich, Kseniya Girel, Sergey V. Redko, Nikolai G. Kovalchuk, I. Komissarov, Vladimir Lukashevich, Igor V. Semak, К. З. Маматкулов, Maria Vorobyeva et al. · 2019 · Biosensors
86. Comparison of Target Enrichment Platforms for Circulating Tumor DNA Detection
    So Ngo Lam, Ying Zhou, Yee Man Chan, Ching Man Foo, Po Yi Lee, Wing Yeung Mok, Wing Sum Wong, Yan Yee Fung, Kit Yee Wong, Jun Yuan Huang et al. · 2020 · Scientific Reports
87. Current therapy of advanced colorectal cancer according to RAS/RAF mutational status
    Gábor Lakatos, Claus‐Henning Köhne, Gyorgy Bodoky · 2020 · Cancer and Metastasis Reviews
88. Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA
    Jonathan C. Dudley, Maximilian Diehn · 2020 · Annual Review of Pathology Mechanisms of Disease
89. ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)
    Laura Masfarré, Joana Vidal, Concepción Fernández‐Rodríguez, Clara O. Montagut · 2021 · Cancers
90. A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA
    Filip Jankú, Helen J. Huang, David Y. Pereira, Masae Kobayashi, Chung Hei Chiu, S. Greg Call, Kristen T. Woodbury, Felix C. Chao, Daniel R. Marshak, Ricky Y. T. Chiu · 2021 · Scientific Reports
91. Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
    Cathy Zhou, Zilong Yuan, Weijie Ma, Lihong Qi, Angelique Mahavongtrakul, Ying Li, Hong Li, Jay Gong, Reggie R. Fan, Jin Li et al. · 2018 · Journal of Hematology & Oncology
92. Next-Generation Sequencing (NGS)
    Min Wang · 2021 · Springer eBooks
93. Second Primary Lung Cancer – An Emerging Issue in Lung Cancer Survivors
    Sarah Østrup Jensen, David Allan Moore, Arif Anwer Surani, Philip A.J. Crosbie, Nitzan Rosenfeld, Robert Campbell Rintoul · 2024 · Journal of Thoracic Oncology
94. Mining nucleic acid “omics” to boost liquid biopsy in cancer
    Ann Tivey, Rebecca J. Lee, Alexandra Clipson, Steven M. Hill, Paul C. Lorigan, Dominic G. Rothwell, Caroline Dive, Florent C. Mouliere · 2024 · Cell Reports Medicine
95. Circulating tumor DNA in lymphoma: technologies and applications
    Lina Fu, Xue‐Rong Zhou, Xiaoyu Zhang, Xuhua Li, Fan Zhang, Hongcang Gu, Xiaoxue Wang · 2025 · Journal of Hematology & Oncology
96. Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
    Wenwei Hu, Yang Yang, Longzhen Zhang, Jianxin Yin, Jingwei Huang, Lei Huang, Hua Gu, Gening Jiang, Jianmin Fang · 2017 · Cancer Medicine
97. Quantification of cyclic DNA polymerization with lanthanide coordination nanomaterials for liquid biopsy
    Wenting Zhou, Lei Wang, Can Liu, Qiuyi Teng, Zhaoyin Wang, Zhihui H. Dai · 2020 · Chemical Science
98. Cell-Free DNA Alterations in the AR Enhancer and Locus Predict Resistance to AR-Directed Therapy in Patients With Metastatic Prostate Cancer
    Ha X. Dang, Pradeep S. Chauhan, Haley Ellis, Wenjia Feng, Peter K. W. Harris, Grace Smith, Mark Qiao, Katherine Dienstbach, Rachel L. Beck, Andrew Atkocius et al. · 2020 · JCO Precision Oncology
99. Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer
    Maria I. Zvereva, Eduard Pisarev, Md. Ismail Hosen, Кисиль Ольга Валерьевна, С.Т. Мацкеплишвили, Elena Aleksandrovna Kubareva, David M. Kamalov, Alexander S. Tivtikyan, Arnaud Manel, Emmanuel Vian et al. · 2020 · International Journal of Molecular Sciences
100. dPCR application in liquid biopsies: divide and conquer
     Andrea Moreno‐Manuel, Silvia Calabuig Fariñas, Antònia Obrador‐Hevia, Ana Blasco, Amaya B. Fernandez-Diaz, Rafael Sirera, Carlos Camps, Eloisa Jantus Lewintre · 2020 · Expert Review of Molecular Diagnostics